First Report of a Noncomplete Clinical Response to Dostarlimab in Locally Advanced Rectal Cancer: Insights into Patient-Related Factors and Implications for Future Therapeutic Management

Clin Colorectal Cancer. 2026 Mar;25(1):164-167. doi: 10.1016/j.clcc.2025.11.002. Epub 2025 Nov 21.
No abstract available

Keywords: Anti PD-1; LARC; Mismatch repair deficient rectal cancer; Neoadjuvant Therapy; Noncomplete clinical response (ncCR).

Publication types

  • Case Reports